Wang Hui, Li Xiangyang, You Xiaoyan, Zhao Guoping
Master Lab for Innovative Application of Nature Products, National Center of Technology Innovation for Synthetic Biology, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences (CAS), Tianjin, 300308, PR China.
Henan Engineering Research Center of Food Microbiology, College of food and bioengineering, Henan University of Science and Technology, Luoyang, 471023, PR China.
Bioact Mater. 2024 Aug 30;42:140-164. doi: 10.1016/j.bioactmat.2024.08.027. eCollection 2024 Dec.
As a powerful paradigm, artificial intelligence (AI) is rapidly impacting every aspect of our day-to-day life and scientific research through interdisciplinary transformations. Living human organoids (LOs) have a great potential for reshaping many aspects of true human organs, including organ development, disease occurrence, and drug responses. To date, AI has driven the revolutionary advances of human organoids in life science, precision medicine and pharmaceutical science in an unprecedented way. Herein, we provide a forward-looking review, the frontiers of LOs, covering the engineered construction strategies and multidisciplinary technologies for developing LOs, highlighting the cutting-edge achievements and the prospective applications of AI in LOs, particularly in biological study, disease occurrence, disease diagnosis and prediction and drug screening in preclinical assay. Moreover, we shed light on the new research trends harnessing the power of AI for LO research in the context of multidisciplinary technologies. The aim of this paper is to motivate researchers to explore organ function throughout the human life cycle, narrow the gap between microphysiological models and the real human body, accurately predict human-related responses to external stimuli (cues and drugs), accelerate the preclinical-to-clinical transformation, and ultimately enhance the health and well-being of patients.
作为一种强大的范式,人工智能(AI)正在通过跨学科变革迅速影响我们日常生活和科学研究的方方面面。活的类器官(LOs)在重塑真实人类器官的许多方面具有巨大潜力,包括器官发育、疾病发生和药物反应。迄今为止,人工智能以前所未有的方式推动了人类类器官在生命科学、精准医学和制药科学方面的革命性进展。在此,我们提供一篇前瞻性综述,介绍类器官的前沿领域,涵盖用于开发类器官的工程构建策略和多学科技术,突出人工智能在类器官中的前沿成就和潜在应用,特别是在生物学研究、疾病发生、疾病诊断与预测以及临床前试验中的药物筛选方面。此外,我们还阐述了在多学科技术背景下利用人工智能推动类器官研究的新研究趋势。本文的目的是激励研究人员探索人类整个生命周期中的器官功能,缩小微生理模型与真实人体之间的差距,准确预测人类对外部刺激(信号和药物)的相关反应,加速临床前到临床的转化,并最终增进患者的健康和福祉。